EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 28 / No 10 (Octobre 2012) Med Sci (Paris), 28 10 (2012) 813-816 References
Free Access
Issue
Med Sci (Paris)
Volume 28, Number 10, Octobre 2012
Page(s) 813 - 816
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20122810005
Published online 12 October 2012
  1. Central brain tumor registry of the United States. www.cbtrus.org (consulté le 26 avril 2012). [Google Scholar]
  2. Van den Bent MJ. Interobserver variation of the histopathological diagnosis in clinical trials on glioma : a clinician’s perspective. Acta Neuropathol 2010 ; 120 : 297–304. [CrossRef] [PubMed] [Google Scholar]
  3. Smith JS, Perry A, Borell TJ, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000 ; 18 : 636–645. [PubMed] [Google Scholar]
  4. Quon H, Abdulkarim B. Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas. Cochrane Database Syst Rev 2008 : CD007104. [PubMed] [Google Scholar]
  5. Houillier C, Wang X, Kaloshi G, et al. IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. Neurology 2010 ; 75 : 1560–1566. [CrossRef] [PubMed] [Google Scholar]
  6. Hegi ME, Diserens AC, Godard S, et al. Clinical trial substantiates the predictive value of 0-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 2004 ; 10 : 1871–1874. [CrossRef] [PubMed] [Google Scholar]
  7. Everhard S, Kaloshi G, Criniere E, et al. MGMT methylation : a marker of response to temozolomide in low-grade gliomas. Ann Neurol 2006 ; 60 : 740–743. [CrossRef] [PubMed] [Google Scholar]
  8. Snuderl M, Fazlollahi L, Le LP, et al. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell 2011 ; 20 : 810–817. [CrossRef] [PubMed] [Google Scholar]
  9. Juillerat-Jeanneret L, Bernasconi CC, Bricod C, et al. Heterogeneity of human glioblastoma : glutathione-S-transferase and methylguanine-methyltransferase. Cancer Invest 2008 ; 26 : 597–609. [CrossRef] [PubMed] [Google Scholar]
  10. Bonavia R, Inda MM, Cavenee WK, et al. Heterogeneity maintenance in glioblastoma: a social network. Cancer Res 2011 ; 71 : 4055–4060. [CrossRef] [PubMed] [Google Scholar]
  11. Yung WK, Vredenburgh JJ, Cloughesy TF, et al. Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study. Neuro Oncol 2010 ; 12 : 1061–1070. [CrossRef] [PubMed] [Google Scholar]
  12. Paulsson J, Lindh MB, Jarvius M, et al. Prognostic but not predictive role of platelet-derived growth factor receptors in patients with recurrent glioblastoma. Int J Cancer 2010 ; 128 : 1981–1988. [CrossRef] [Google Scholar]
  13. Natsume A, Kinjo S, Yuki K, et al. Glioma-initiating cells and molecular pathology: implications for therapy. Brain Tumor Pathol 2011 ; 28 : 1–12. [CrossRef] [PubMed] [Google Scholar]
  14. Ducray F, Mokhtari K, Criniere E, et al. Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas. Eur J Cancer 2011 ; 47 : 802–808. [CrossRef] [PubMed] [Google Scholar]
  15. SongTao Q, Lei Y, Si G, et al. IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma. Cancer Sci 2011 ; 103 : 269–273. [CrossRef] [PubMed] [Google Scholar]
  16. Van den Bent MJ, Dubbink HJ, Sanson M, et al. MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951. J Clin Oncol 2009 ; 27 : 5881–5886. [CrossRef] [PubMed] [Google Scholar]
  17. Jha P, Suri V, Jain A, et al. 06-methylguanine DNA methyltransferase gene promoter methylation status in gliomas and its correlation with other molecular alterations: first Indian report with review of challenges for use in customized treatment. Neurosurgery 2010 ; 67 : 1681–1691. [CrossRef] [PubMed] [Google Scholar]
  18. Zawlik I, Vaccarella S, Kita D, et al. Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study. Neuroepidemiology 2009 ; 32 : 21–29. [CrossRef] [PubMed] [Google Scholar]
  19. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003 ; 63 : 5821–5828. [Google Scholar]
  20. Molina JR, Hayashi Y, Stephens C, et al. Invasive glioblastoma cells acquire stemness and increased Akt activation. Neoplasia 2010 ; 12 : 453–463. [PubMed] [Google Scholar]
  21. Hoelzinger DB, Mariani L, Weis J, et al. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 2005 ; 7 : 7–16. [CrossRef] [PubMed] [Google Scholar]
  22. Gole B, Huszthy PC, Popovic M, et al. The regulation of cysteine cathepsins and cystatins in human gliomas. Int J Cancer 2012 (online). doi : 10.1002/ijc.27453. [Google Scholar]
  23. Mariani L, Beaudry C, McDonough WS, et al. Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro. Clin Cancer Res 2001 ; 7 : 2480–2489. [PubMed] [Google Scholar]
  24. Seidel S, Garvalov BK, Wirta V, et al. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. Brain 2010 ; 133 : 983–995. [CrossRef] [PubMed] [Google Scholar]
  25. Rong Y, Durden DL, Van Meir EG, et al. Pseudopalisading necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis. J Neuropathol Exp Neurol 2006 ; 65 : 529–539. [CrossRef] [PubMed] [Google Scholar]
  26. Charalambous C, Chen TC, Hofman FM. Characteristicsof tumor-associated endothelial cells derived from glioblastoma multiforme. Neurosurg Focus 2006 ; 20 : E22. [CrossRef] [PubMed] [Google Scholar]
  27. Miebach S, Grau S, Hummel V, et al. Isolation and culture of microvascular endothelial cells from gliomas of different WHO grades. J NeuroOncol 2006 ; 76 : 39–48. [CrossRef] [PubMed] [Google Scholar]
  28. Dahlstrand J, Collins VP, Lendahl U. Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res 1992 ; 52 : 5334–5341. [PubMed] [Google Scholar]
  29. Shih AH, Holland EC. Notch signaling enhances nestin expression in gliomas. Neoplasia 2006 ; 8 : 1072–1082. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.